{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:14:40Z","timestamp":1787019280749,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["57600578"],"award-info":[{"award-number":["57600578"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI156766"],"award-info":[{"award-number":["R21 AI156766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107628","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:41:16Z","timestamp":1758584476000},"page":"107628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolate"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9452-9865","authenticated-orcid":false,"given":"Aneeq","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0397-820X","authenticated-orcid":false,"given":"Sue C.","family":"Nang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-7484","authenticated-orcid":false,"given":"Hasini","family":"Wickremasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8773-4845","authenticated-orcid":false,"given":"Sebastian G.","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107628_bib0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/IDR.S287792","article-title":"Encouraging the development of new antibiotics: are financial incentives the right way forward? A systematic review and case study","volume":"14","author":"Dutescu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0002","unstructured":"Lack of new antibiotics threatens global efforts to contain drug-resistant infections. https:\/\/www.who.int\/news\/item\/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections [accessed 12.25.2024]."},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0003","unstructured":"World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. https:\/\/www.who.int\/publications\/i\/item\/9789240093461 [accessed 07.26.2024]."},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0006","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/antibiotics12040751","article-title":"A century of clinical use of phages: a literature review","volume":"12","author":"Diallo","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0007","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(05)74059-9","article-title":"Phage therapy\u2014advantages over antibiotics?","volume":"356","author":"Pirisi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0009","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resmic.2012.08.008","article-title":"Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa","volume":"164","author":"Knezevic","year":"2013","journal-title":"Res Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0012","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.csbj.2021.12.039","article-title":"Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination","volume":"20","author":"Han","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0014","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2212activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0015","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/acsinfecdis.1c00366","article-title":"Exploitation of a Klebsiella bacteriophage receptor-binding protein as a superior biorecognition molecule","volume":"7","author":"Nogueira","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0016","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/jac\/dkz314","article-title":"Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1","volume":"74","author":"Nang","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0017","doi-asserted-by":"crossref","first-page":"e00100","DOI":"10.1128\/cmr.00100-22","article-title":"Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values\u2014Laboratory and clinical utility","volume":"36","author":"Kahlmeter","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0018","doi-asserted-by":"crossref","first-page":"e2261","DOI":"10.7717\/peerj.2261","article-title":"Phage on tap\u2013a quick and efficient protocol for the preparation of bacteriophage laboratory stocks","volume":"4","author":"Bonilla","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0019","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","article-title":"Handling data below the limit of quantification in mixed effect models","volume":"11","author":"Bergstrand","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110825","article-title":"Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy","volume":"39","author":"Delattre","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01929-y","article-title":"A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions","volume":"8","author":"Wicha","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0023","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000253","article-title":"Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy","volume":"5","author":"Cairns","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009172","article-title":"Mechanisms and therapeutic potential of collateral sensitivity to antibiotics","volume":"17","author":"Roemhild","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0026","doi-asserted-by":"crossref","first-page":"e1418","DOI":"10.1002\/hsr2.1418","article-title":"Collateral sensitivity: an evolutionary trade-off between antibiotic resistance mechanisms, attractive for dealing with drug-resistance crisis","volume":"6","author":"Yekani","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0027","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3389\/fmicb.2018.01832","article-title":"Adapted bacteriophages for treating urinary tract infections","volume":"9","author":"Ujmajuridze","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0028","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107628_bib0029","unstructured":"ClinicalTrials.gov Identifier: NCT06870409. Bacteriophages in addition to antibiotics for the treatment of patients with infective endocarditis. https:\/\/clinicaltrials.gov\/study\/NCT06870409 [accessed 09.10.2025]."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:12:52Z","timestamp":1775517172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001839"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107628","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolate","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107628"}}